Description:
Relvar Ellipta 200/25 Microgram is an inhalation powder used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This combination inhaler delivers a fixed dose of two active ingredients to help control and prevent symptoms such as wheezing, shortness of breath, and tightness in the chest. The Ellipta device is designed for ease of use, ensuring consistent delivery of medication with each inhalation.
Ingredients:
- Active Ingredients:
- Fluticasone Furoate 200 micrograms
- Vilanterol Trifenatate 25 micrograms
- Inactive Ingredients: [List any other relevant ingredients, such as lactose.]
Usage Instructions:
-
Dosage: One inhalation (200/25 micrograms) once daily.
-
Frequency: Use at the same time each day for best results.
-
Special Considerations: Rinse your mouth with water after inhalation to reduce the risk of oral thrush. Do not swallow the rinse water. If you miss a dose, take it as soon as you remember, but do not take more than one dose in a day.
Benefits:
- Provides long-term control of asthma and COPD symptoms.
- Reduces inflammation and relaxes the muscles in the airways.
- Improves breathing and overall lung function.
- Convenient once-daily dosing with an easy-to-use inhaler.
Precautions:
- Not for use in the immediate relief of acute asthma attacks or COPD exacerbations.
- Do not use if allergic to any of the ingredients.
- Consult a healthcare provider if you experience worsening symptoms, such as increased shortness of breath
- Potential side effects include bruising, bleeding, and injection site reactions.
Storage Instructions:
- Store in the refrigerator (2°C to 8°C) until the first use.
- Once in use, the pen can be stored at room temperature (up to 30°C) for up to 56 days.
- Keep away from direct heat and sunlight.
- Do not freeze.
Manufacturer: GlaxoSmithKline Pharmaceuticals
